Caryn Gordon McDowell

GC & Chief Compliance Officer, Cytokinetics.

Companies

IRulya Therapeutics Inc.General counsel May 15, 2020 to Jun 8, 2022¹
Revance Therapeutics, Inc.SVP, GC & Secretary May 3, 2018 to Feb 19, 2020²
CytokineticsGC & Chief Compliance Officer May 20, 2016 to Mar 1, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IRulya Therapeutics Inc. QNCX122,500 shares⁴$3.9M at $32.03Jun 6, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 6, 2022Sold 10,800 shares at $2.86 of IRulya Therapeutics Inc.⁴
Jun 6, 2022Shares withheld for tax 6,700 shares at $2.86 of IRulya Therapeutics Inc.⁴
Mar 3, 2022Granted 140,000 shares of IRulya Therapeutics Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIRulya Therapeutics Inc., General counsel
2
SEC EDGARRevance Therapeutics, Inc., SVP, GC & Secretary
3
SEC EDGARCytokinetics, GC & Chief Compliance Officer
4
SEC EDGARIRulya Therapeutics Inc. shares after the filing of Jun 6, 2022
5
SEC EDGARForm 4 filed Mar 4, 2022